EyePoint Pharmaceuticals, Inc. (EYPT) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Number of Patients Enrolled Across LUGANO and LUCIA Trials | 900.00 | FY2026-Q2 |
| Net Product Revenue | 467K | FY2026-Q1 |
| Net Revenue from Licenses and Royalties | 300K | FY2025-Q4 |
Back to EYPT overview · EYPT earnings · EYPT holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.